Long-term osteoprotective effects of IL-17A blockade with secukinumab in psoriatic arthritis: data from the PSARTROS-II studyLouis Schuster, Filippo Fagni, Melek Yalcin Mutlu et al.|RMD Open|2026Cited by 0